TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TRML Stock 12 Month Forecast
There Are No Analyst Ratings for TRML In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
TRML Financial Forecast
TRML Earnings Forecast
Next quarter’s earnings estimate for TRML is -$0.91 with a range of -$0.97 to -$0.81. The previous quarter’s EPS was -$0.90. TRML beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year TRML has Performed in-line its overall industry.
Next quarter’s earnings estimate for TRML is -$0.91 with a range of -$0.97 to -$0.81. The previous quarter’s EPS was -$0.90. TRML beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year TRML has Performed in-line its overall industry.
No data currently available
TRML Sales Forecast
Next quarter’s sales forecast for TRML is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TRML beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year TRML has Performed in-line its overall industry.
Next quarter’s sales forecast for TRML is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TRML beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year TRML has Performed in-line its overall industry.
Cantor Fitzgerald reiterates Overweight Rating on Tourmaline Bio (TRML)Cantor Fitzgerald analyst Josh Schimmer reiterated an Overweight rating and {REMOVEPT} price target on Tourmaline Bio (NASDAQ: TRML).
Cantor Fitzgerald reiterates Overweight Rating on Tourmaline Bio (TRML)Cantor Fitzgerald analyst Josh Schimmer reiterated an Overweight rating and {REMOVEPT} price target on Tourmaline Bio (NASDAQ: TRML).
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +19.42% per trade.
trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +30.15% per trade.
Copying Thomas Smith's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +68.68% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +132.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TRML Analyst Recommendation Trends
Rating
Apr 25
May 25
Jul 25
Aug 25
Sep 25
Strong Buy
13
21
15
14
6
Buy
3
3
2
1
2
Hold
1
1
0
0
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
25
17
15
18
In the current month, TRML has received 8Buy Ratings, 10Hold Ratings, and 0Sell Ratings. TRML average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
TRML Stock Forecast FAQ
What is TRML’s average 12-month price target, according to analysts?
Currently, no data Available
What is TRML’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TRML, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TRML a Buy, Sell or Hold?
Currently, no data Available
What is Tourmaline Bio, Inc.’s price target?
Currently, no data Available
What do analysts say about Tourmaline Bio, Inc.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TRML?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.